Table 5. Pleiotropy testing of myocardial infarction (exposure) and plasma metabolites (outcome).

Exposures	Outcome ID	Outcome traits	Egger intercept	P-value
Myocardial infarction	GCST90199705	Propionylglycine levels	0.005	0.913
Myocardial infarction	GCST90199741	Gamma-glutamylglycine levels	0.005	0.785
Myocardial infarction	GCST90199807	Hexadecanedioate (C16-DC) levels	0.005	0.143
Myocardial infarction	GCST90200054	1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels	0.006	0.449
Myocardial infarction	GCST90200059	Behenoyl dihydrosphingomyelin (d18:0/22:0) levels	0.006	0.019
Myocardial infarction	GCST90200065	1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels	0.005	0.728
Myocardial infarction	GCST90200259	Pentose acid levels	0.005	0.396
Myocardial infarction	GCST90200438	Alpha-ketobutyrate levels	0.005	0.016
Myocardial infarction	GCST90200630	X-24546 levels	0.005	0.061
Myocardial infarction	GCST90200680	5-acetylamino-6-formylamino-3-methyluracil levels	0.006	0.900
Myocardial infarction	GCST90200707	Glycine levels	0.005	0.846
Myocardial infarction	GCST90200726	N-acetylputrescine to (N (1) + N (8))-acetylspermidine ratio	0.005	0.545
Myocardial infarction	GCST90200758	Glycine to serine ratio	0.005	0.890
Myocardial infarction	GCST90200782	Mannose to trans-4-hydroxyproline ratio	0.005	0.424